background. ART patients demonstrated a two-fold odds of preterm delivery (PTD) <37 and 34 weeks (1.90 [1.10 -3.30 ] and 2.51 [0.99 -6 .38], respectively. In the OS/IUI group these odds were higher as compared with IVF/ICSI group ] vs 1. 38 [0.62 -3.09] , and 3.7 [1. 13 -12.29 ] vs 1.67 [0.39 -7 .04]) for PTD <37 week and PTD <34 week, respectively. Even more, the OS/IUI showed an almost three times higher odds for small gestational age <p10 (OR=2.66 [1. 03 -6.86] ). IVF/ICSI group was only associated with a three-fold increase odds of Caesarean section (OR=3.02 [1.58 -5 .78]), with normal birthweight and non-significant lower rates of Pre-eclampsia compared to controls (1.8% vs 3.7%). Conclusions: ART pregnancies, and particularly OS/IUI, are associated with an increased risk of preterm delivery and low birthweight.
P21.02
In high-risk women, first trimester blood pressure elevation below current treatment thresholds leads to pre-eclampsia Objectives: First trimester (T1) multi-marker screening algorithms for pre-eclampsia (PE;T1 PE screen) incorporate risk factors for impaired placentation that are thought to lead to clinical disease later in pregnancy. The T1 PE screen universally is most accurate when maternal blood pressure (BP) is incorporated into the risk estimate. Early gestational BP elevation may therefore be a primary mediator of subsequent PE. We aimed to study if development of PE is independently determined by maternal BP at the time of first trimester screening. Methods: Women were prospectively enrolled for a T1 PE screen. Demographics, past history, physical exam, BP, uterine artery Doppler, and biomarkers were obtained. Individual PE risk was calculated (NTD Labs, Eurofin); a risk of ≥ 1:200 was considered screen-positive. Serial BP measurements throughout gestation in screen-positive women were related to development of subsequent PE. Results: Forty-nine of 758 women (6.5%) were T1 PE screen-positive and had 647 serial BPs between 4-41 weeks gestation. Nine (18.4%) women developed PE, and these women had higher average systolic BP (SBP in T1:130 vs 115; T2:130 vs 115; T3: 140 vs 118 mmHg) and diastolic BP (DBP in T1: 81 vs 70; T2: 84 vs 69; T3: 88 vs 72 mmHg) throughout all trimesters (Mann Whitney U, p< 0.0001 for all). Serial BP tracking showed significantly higher values for SBP, DBP, and mean arterial BP (MAP) from the T1 onward. Independent of the personalised PE risk, logistic regression identified T1 SBP and T2 DSP as the primary factors for subsequent PE (B=1.108 and 1.321, r 2 0.49, p < 0.0001). ROC analysis identified an average T1 SBP > 135 mmHg to be associated with the highest risk for subsequent PE. Conclusions: Maternal BP determines the risk for PE from the onset of pregnancy. In at-risk women, T1 BP elevations below the currently recommended treatment threshold head to PE. Treatment thresholds for maternal BP therefore require re-evaluation, particularly in the subset of women with elevated PE risk based upon T1 pre-eclampsia screening.
P21.03
First trimester pre-eclampsia screening in low-risk nulliparous women: the great obstetrical syndrome (GOS) study Objectives: To evaluate the Fetal Medicine Foundation (FMF) algorithm discriminative ability for the prediction of preterm pre-eclampsia (PE) in low risk nulliparous women. Methods: We conducted a prospective cohort study of Canadian nulliparous women with singleton living fetus recruited at 11-14 weeks. Women with chronic disease (hypertension, diabetes, rheumatic or renal diseases, APS), and those with pregnancies complicated by fetal anomaly, medical termination, or spontaneous abortion before 20 weeks, were excluded. Maternal age, BMI, methods of conception, ethnicity, mean arterial blood pressure, PAPP-A, PlGF and mean uterine artery pulsatility index were submitted into the online FMF algorithm. Familial history of pre-eclampsia was not collected and considered as absent for all participants. Native American ethnicity was not available and entered as ''mixed'' in the model or removed in a sensitivity analysis. Simple imputation was used for the treatment of missing values. Area under the curve (AUC) and their 95% CI, and detection rates of preterm PE for 10% and 15% false-positive rates were calculated. Results: We included 4470 participants recruited at a mean gestational age of 13.0±0.6 weeks, including 31 cases of preterm PE (0.7%). We observed a good discrimination of preterm PE by the FMF risk algorithm (AUC: 0.80; 95% CI: 0.71 to 0.89). For a 10% or 15% false-positive rate, we would have detected 52% or 68% of preterm PE, respectively. Analyses with complete observations and simple imputation raised similar results. Conclusions: In a low-risk population of nulliparous women without chronic disease, the FMF algorithm remains strongly predictive of preterm PE. The role of Native American ethnicity should be further explored.
P21.04
First trimester prediction of pre-eclampsia in high-risk women using 3D power Doppler placental vascularisation indices Objectives: 3D power Doppler (3DPD) imaging of the placenta enables evaluation of Placental Vascularisation Indices (PVIs). The aim of this study was to examine the ability of Vascularisation Index (VI, %), Flow Index (Fl) and Vascularisation Flow Index (VFI) to predict pre-eclampsia (PET) in four groups of high risk women: (1) diabetes (type 1 and 2) (2) booking Body Mass Index (BMI) >35kg/m 2 (3) hypertension, renal disease, intrauterine growth restriction (4) thrombophilia, autoimmune disease. Methods: Analysis was performed among women (n=194) recruited to the PREDICT study (prediction of PET in high-risk women). Women were recruited between 11+0 and 13+6 weeks gestation from a tertiary referral centre in Northern Ireland. PVIs were derived from 3DPD whole placental volume scanning via Virtual Organ Computer-aided Analysis (VOCAL) technique. Logistic regression models using PET as the outcome were determined for each PVI. Covariates included: study group, age, BMI, smoking status, aspirin use, parity, material deprivation of area of residence and Mean Arterial Pressure (MAP). Results: The overall rate of PET was 12%. No significant differences in age, smoking status, deprivation or MAP were seen between groups. Significant differences in parity (P=0.002), BMI (P<0.001) and aspirin use (P<0.001) were noted. In the logistic regression model, a 1% increase in VI from a mean of 14.2 (SD 7.7) to 15.2% was associated with a 10% reduction in the odds of PET (OR 0.90, 95% CI 0.82-0.98, P=0.02) and a 1 unit increase in FI (mean 42.1, SD 10.3) was associated with a 6% reduction in the odds of PET (OR 0.94, 95% CI 0.89-1.0, P=0.04). A doubling in VFI (median 5.1, 3) was associated with a 57% reduction in the odds of PET (OR 0.43, P=0.001) . Conclusions: Using logistic regression, VI, FI and VFI were predictive of PET in separate models controlling for confounding variables. This technique may be a useful adjunct for clinicians wishing to refine first trimester screening models to predict PET.
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Prediction of pre-eclampsia by biochemical and biophysical markers at first trimester among Mongolian pregnant women
U. Tserensambuu

Obstetrics and Gynecology Hospital, National Centre for Maternal and Child Health of Mongolia, Ulaanbaatar, Mongolia
Objectives Screening and assessment of pre-eclampsia by PAPP-A, PlGF, MAP, and mPI at first trimester of gestation. Methods: The study conducted among 361 singleton pregnant women at 11-13 +6 weeks, who were visiting antenatal care services, between March, 2015 and January, 2016. The cross sectional study design was used to implement this study. The ethical norms of biomedical research were applied throughout the course of study. The PlGF, PAPP-A in plasma were identified by PerkinElmer kits, uterine artery pulsatility index measured by GE ultrasound machine, the blood pressure was measured twice, in each arm of pregnant woman, by Omron blood pressure monitor. Results: The PIGF level of the group with pre-eclampsia complications was 38.6±19.6 pg/ml, in the group without pre-eclampsia level was 45.1±24.0 pg/ml (p=0.010), while PAPP-A concentration in the group with pre-eclampsia was 366.1±195.3 mU/L and 633.6±496.9 mU/L (p=0.003) in the group without pre-eclampsia. MAP 80.1-100 mm Hg group had 20.6 times higher risk of pre-eclampsia in compare to MAP normal group (OR 20.6, p=0.003) . No significant differences observed in mPI of both groups (p=0.222).
The logistic regression analysis shows that pregnant women previous without pre-eclampsia but have MAP more than 80mm Hg, PAPP-A less than 330 mU/L and PIGF less than 35pg/ml or have three risk factors of pre-eclampsia (OR 8.12 p=0.018) have higher level of pre-eclampsia compared to women with 1 or 2 risk factors . Conclusions: In the groups of pregnant women with pre-eclampsia, the levels of PlGF, PAPP-A are lower compared to those, who have no pre-eclampsia. The level of risk of pre-eclampsia for women without previous pre-eclampsia depends on the number of risk factors.
